No Data
He Family Eye Hospital (301103.SZ): Currently, it has not yet accessed the DeepSeek large model.
On February 19, Gelonghui reported that He Family Ophthalmology (301103.SZ) stated on the investor interaction platform that the company has not yet connected to the DeepSeek large model. The company has been closely monitoring the technological evolution and industry applications in the field of AI, including but not limited to cutting-edge directions such as the DeepSeek large model. The company is planning to apply various AI tools supported by Transformer as the underlying technology to create greater value in customer relationship establishment and internal process efficiency.
He Ne's Ophthalmology (301103.SZ): Currently not involved in AI drug development.
Gelonghui February 19丨He Family Ophthalmology (301103.SZ) stated on the investor interaction platform that the company's main business is Ophthalmology Medical Services, and it is also a group-based chain Medical Services institution. Currently, it does not involve AI pharmaceutical production.
Shareholders of He Family Ophthalmology (301103.SZ), Meixin Fund and Pengxin Fund, have collectively reduced their Shareholding by 0.6851 million shares.
He Shi Ophthalmology (301103.SZ) announced that the Shareholders Meixin Fund and Pengxin Fund have concluded their shareholding plans ahead of schedule, total...
He Eye Hospital (301103.SZ) issued a pre-loss announcement, expecting a net loss of 20.5 million yuan to 30.75 million yuan for the fiscal year 2024, turning from profit to loss.
He Eye Hospital (301103.SZ) released its performance forecast for 2024, the company expects that for the year 2024, the net profit attributable to...
Ho\'s Ophthalmology: 2024 performance forecast
He Eye Hospital (301103.SZ): Expansion prefers economically developed regions.
On January 14, Gelonghui reported that He’s Eye Hospital (301103.SZ) announced on the investor interaction platform that the areas prioritized for the company's expansion are economically developed regions, focusing on JING-JIN-JI, the Chengdu-Chongqing urban agglomeration, and the CNI Zhujiang Index, with Consumer Medical as the key area for expansion, planning to adopt a combination of self-built and franchise chain methods.
Liaoning He Eye Hospital Group (SZSE:301103) Could Be Struggling To Allocate Capital
